Posts

Posted on

Zhihu Inc. Announces Proposed Subscription in AI-Focused Investment Fund

BEIJING, China, Sept. 06, 2026 (GLOBE NEWSWIRE) — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced that the Company, through a wholly owned subsidiary, has entered into a subscription agreement for a limited partnership interest in Tianjin Lisi Xingshen Equity Investment Partnership (Limited Partnership) (the “Fund”), subject to approval by the Company’s shareholders at an extraordinary general meeting (“EGM”).

The proposed subscription involves a capital commitment of RMB1.5 billion, payable in cash pursuant to the Fund’s capital call arrangements. The Company expects that its interest in the Fund will be no more than 30% immediately following completion of the proposed subscription.

The Fund will primarily invest, directly or indirectly, in early-to-mid-stage unlisted enterprises in the field of AI and related technology sectors established or operating in, or with other significant nexus to, mainland China. The Fund will adopt a blind pool structure, and the Fund’s investment targets have not yet been determined. The Company, as a limited partner, will not participate in the Fund’s day-to-day management or specific investment decisions.

The Company believes that the proposed subscription will enable it to leverage the fund manager’s sector expertise, industry resources and investment capabilities to broaden its access to high-quality AI and technology investment opportunities, deepen its understanding of emerging technologies, products and business models, and explore potential collaboration opportunities across the broader AI ecosystem.

The proposed subscription does not represent a change in the Company’s principal business or strategic focus. Zhihu will continue to focus on the development of its online content community and core businesses, while prudently evaluating AI-related business opportunities and pursuing disciplined capital allocation with a view to creating long-term value for its shareholders.

The proposed subscription constitutes a major transaction under Chapter 14 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and is subject to shareholders’ approval at an EGM that the Company plans to convene in the near future. Further information regarding the proposed subscription is available in the Company’s announcement published on the website of the Hong Kong Stock Exchange on September 6, 2026.

About Zhihu Inc.

Zhihu Inc. (NYSE: ZH; HKEX: 2390) is a leading online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Since the initial launch in 2010, Zhihu has grown into the largest Q&A-inspired online content community in China. For more information, please visit https://ir.zhihu.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC and the Hong Kong Stock Exchange. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

For investor and media inquiries, please contact:

Zhihu Inc.

Email: [email protected]

Christensen Advisory

Roger Hu
Tel: +86-10-5900-1548
Email: [email protected]



Posted on

Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call

BASEL, Switzerland and LONDON and NEW YORK, Sept. 06, 2026 (GLOBE NEWSWIRE) — Roivant (Nasdaq: ROIV) and Pulmovant today announced that results from the Phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) will be presented at the European Respiratory Society (ERS) International Congress 2026 at 12:15 CEST (6:15 a.m. ET) on Tuesday, September 8, 2026, by Marc Humbert, MD, PhD, Professor of Respiratory Medicine at Université Paris-Saclay and Director of the French National Reference Center for Pulmonary Hypertension. Roivant will also host an investor call and webcast at 8:00 a.m. ET on Tuesday, September 8, 2026.

To access the conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under “Events & Presentations” in the Investors section of the Roivant website at www.investor.roivant.com/news-events/events.  The archived webcast will be available on Roivant’s website after the conference call.

About Roivant

Roivant (Nasdaq: ROIV) is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant’s pipeline includes LISRAYA™ (brepocitinib), a potent small molecule inhibitor of JAK1 and TYK2 FDA-approved for the treatment of dermatomyositis in adult patients and also in late-stage development for the treatment of non-infectious uveitis, cutaneous sarcoidosis and lichen planopilaris; IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. We advance our pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies. For more information, visit www.roivant.com.

Forward-Looking Statements

This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are usually identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations of such words or similar expressions. The words may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act.

Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, and statements that are not historical facts, including statements about the clinical and therapeutic potential of our product and product candidates, the availability and success of topline results from our ongoing clinical trials, any commercial potential of our product and product candidates following applicable regulatory approvals and the outcome of any pending litigation. In addition, any statements that refer to projections, forecasts or other characterizations of future events, results or circumstances, including any underlying assumptions, are forward-looking statements. Actual results may differ materially from those contemplated in these statements due to a variety of risks, uncertainties and other factors.

Although we believe that our plans, intentions, expectations and strategies as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number of risks, uncertainties and assumptions, including, but not limited to, those risks set forth in the Risk Factors section of our filings with the U.S. Securities and Exchange Commission. Moreover, we operate in a very competitive and rapidly changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of our management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, we assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts:

Investors

Keyur Parekh
[email protected] 

Media

Stephanie Lee
[email protected] 



Posted on

PHH, BYAH Deadline: PHH, BYAH Investors with Losses in Excess of $100K Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit

PR Newswire

NEW YORK, Sept. 5, 2026 /PRNewswire/ —

Rosen Law Firm Logo

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.

So what: If you purchased Park Ha securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Park Ha class action, go to https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Park Ha’s business, operations, and the true nature of its securities trading activity. Specifically, defendants failed to disclose that: (1) Park Ha was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) Park Ha’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; (3) Park Ha’s IPO was intentionally structured with an extremely low public float to enable the manipulation scheme; and (4) as a result of the foregoing, defendants’ positive statements about Park Ha’s business, operations, and prospects were misleading and/or lacked a reasonable basis.

To join the Park Ha class action, go to https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/phh-byah-deadline-phh-byah-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302870523.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai’i

At a glance

  • Customer relief offer: We are waiving calling, texting and data charges on Kaua’i to help our consumer and small business customers connect with loved ones.
  • Strengthened network infrastructure: We have prepared our Hawai’i network with backup generators, satellite assets, and pre-staged equipment designed for reliability during severe weather.
  • Satellite messaging: Verizon customers can maintain essential communications via satellite, allowing compatible phones to send text messages or connect with emergency services.
  • Proactive collaboration: We are working directly with the Hawai’i Emergency Management Agency (HIEMA), local power providers, and public safety officials to support critical infrastructure.
  • Customer resources: We offer essential digital preparedness steps to help residents and businesses stay connected and secure ahead of the storm.

HONOLULU, Hawaii, Sept. 05, 2026 (GLOBE NEWSWIRE) — As Major Hurricane Lowell approaches Hawai’i, Verizon will waive domestic call, text, and data charges. This relief offer applies through September 14 for prepaid* and postpaid consumer customers as well as small business customers** throughout Kaua’i.

Customers do not have to take any action to take advantage of the offer.

In addition, Verizon has taken proactive, on-the-ground measures across the islands to protect connectivity. The company’s focus: keeping customers, local businesses and public safety partners connected when it matters most.

“We know how stressful it is for the people of Hawaiʻi to brace for yet another storm,” said Aimee Novak, West Area President for Verizon. “Our commitment to this community is enduring and our focus right now is keeping you connected to the people and services that matter most. With Hurricane Lowell approaching, our response teams remain fully activated, and we owe a massive thank you to the local crews working around the clock to support this community once again.”

Verizon’s network preparation strategy for Hawai’i

Verizon’s network infrastructure in Hawai’i is engineered to withstand severe weather. A significant portion is backed by fully refueled permanent site generators providing multiple days of backup power reserves. At sites without permanent generators, we have portable generators and other backup solutions available for deployment. To further reinforce operational resilience against potential disruptions, Verizon engineers have satellite assets available to dispatch as needed.

Verizon is working directly with local power companies, the Hawai’i Emergency Management Agency (HIEMA), and state public safety officials. The company remains on constant standby to safeguard critical communications.

How residents and businesses can prepare now

Hurricane Lowell is the third tropical system this year to threaten the state, but with the size and strength of this storm, it’s especially important residents finalize their personal digital preparedness plans:

  1. Charge devices: Keep all mobile devices, tablets, and portable power banks fully charged well before storm watches or warnings are issued for your location.
  2. Protect your gear: Place phones, chargers, and external batteries in waterproof accessories or heavy-duty zip-lock bags to safeguard them against floodwaters or rain.
  3. Establish a communication plan: Coordinate a dedicated ohana (family) emergency plan and save key emergency contact numbers directly to your devices.
  4. Check on your kūpuna (elders): To ensure their devices are charged and they have an emergency communication plan in place.
  5. Secure visual backups: Take photos of your home, vehicle, and valuables for insurance purposes. Ensure these images are uploaded to the cloud so you can access them even if your phone is lost or damaged.
  6. Utilize digital resources: Download critical weather tracking, news, and American Red Cross safety apps ahead of time.
  7. Mitigate customer disruption: List critical software, equipment, service contracts and vital contacts (utilities, vendors, authorities) needed to maintain operations. Review coverage with your insurance agent to eliminate gaps.
  8. Contacts and documents are key: Centralize updated contact info for all staff (including remote and satellite offices) and keep accessible, secure copies of your insurance policies.
  9. Keep track of equipment: Maintain an inventory of all corporate hardware deployed to remote employees to streamline claims for potential loss or damage.
  10. The right tech makes an impact: Secure the mobile-ready technology and infrastructure needed to maintain business connectivity if you are forced to relocate.
  11. Have a backup plan: Establish a protocol to immediately reroute workloads if remote employees lose power or face evacuation.

Should terrestrial services become unavailable, Verizon encourages customers with compatible satellite-enabled devices (such as iPhone 14 or newer running iOS 18+, or Google Pixel 9 or newer) to test emergency satellite messaging features before the storm begins to cause impacts.

Verizon will continue monitoring Hurricane Lowell and will provide local network status updates as necessary. Customers can track real-time network status using the Check Network Status tool on Verizon’s website or directly within the My Verizon mobile app.


Visit the Emergency Resource Center for further details on Verizon’s emergency response capabilities.

*For Value customers impacted, we are extending the service end dates. This includes customers across Verizon’s value brands, including Straight Talk, Tracfone, Total Wireless, Walmart Family Mobile, Page Plus, Simple Mobile, SafeLink Wireless, and Net10 Wireless.
**Verizon small business customers include customers with 50 lines or less.

This announcement was originally published by Verizon. Read the original press release.

Verizon Communications Inc. (NYSE, Nasdaq: VZ) powers and empowers how its millions of customers live, work and play, delivering on their demand for mobility, reliable network connectivity and security. Headquartered in New York City, serving countries worldwide and nearly all of the Fortune 500, Verizon generated revenues of $138.2 billion in 2025. Verizon’s world-class team never stops innovating to meet customers where they are today and equip them for the needs of tomorrow. For more, visit verizon.com or find a retail location at


verizon.com/stores


.

VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at verizon.com/news. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.

Media contacts: 

Pete Burd
[email protected]

Meagan Dorsch
[email protected]



Posted on

DVLT Investors Have Opportunity to Lead Datavault AI Inc. Securities Fraud Lawsuit

PR Newswire

NEW YORK, Sept. 5, 2026 /PRNewswire/ —

Rosen Law Firm Logo

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Datavault AI Inc. (NASDAQ: DVLT) between September 4, 2024 and October 30, 2025, inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline.

So what: If you purchased Datavault AI securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Datavault AI class action, go to https://rosenlegal.com/cases/datavault-ai-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 5, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made materially false and/or misleading statements and or failed to disclose that: (1) defendants had overstated the economic value to Datavault AI of its various corporate partnerships with, inter alia, Burke, Scilex, and Nature’s Miracle; (2) Defendants had overstated the volume of trading activity on the Datavault Platform, which was in fact minimal; (3) Datavault’s undisclosed connections with Edward Withrow III, a convicted felon, when revealed, would cause Datavault AI to incur reputational harm; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times.

To join the Datavault AI class action, go to https://rosenlegal.com/cases/datavault-ai-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dvlt-investors-have-opportunity-to-lead-datavault-ai-inc-securities-fraud-lawsuit-302870468.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Unicycive Therapeutics, Inc. (“Unicycive” or “the Company”) (NASDAQ: UNCY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of UNCY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: December 29, 2025 to June 29, 2026

DEADLINE: November 2, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Unicycive failed to inspect its third-party manufacturing partner to ensure compliance with good manufacturing practices. The Company had no support for the belief that its vendor resolved deficiencies identified by the FDA. The Company suffered from an undisclosed risk of further scrutiny by the FDA. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Unicycive, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Schall, Brown & Schwartz LLP

Brian Schall, Esq.,

Andrew Brown, Esq.,

David Schwartz, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo
Posted on

PZZA Investors Have Opportunity to Lead Papa John’s International, Inc. Securities Fraud Lawsuit with SBS Law

PZZA Investors Have Opportunity to Lead Papa John’s International, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Papa John’s International, Inc. (“Papa John’s” or “the Company”) (NASDAQ: PZZA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of PZZA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: August 7, 2025 to August 5, 2026

DEADLINE: November 2, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. The transformation plan developed by Papa John’s was not achieving results in the expected timeframe. The Company failed to prevent further erosion in market share. The Company was forced to sharply increase promotional efforts to preserve market share. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Papa John’s, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Schall, Brown & Schwartz LLP

Brian Schall, Esq.,

Andrew Brown, Esq.,

David Schwartz, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo
Posted on

SMAR Investors Have Opportunity to Lead Smartsheet Inc. Securities Fraud Lawsuit

PR Newswire

NEW YORK, Sept. 5, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Smartsheet Inc. (NYSE: SMAR) between June 1, 2024 and September 23, 2024, both dates inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline.

Rosen Law Firm Logo

So what: If you purchased Smartsheet common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Smartsheet class action, go to https://rosenlegal.com/cases/smartsheet-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 5, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, on January 24, 2024, Smartsheet received an unsolicited non-public offer from a consortium of investors (the “Consortium”) to purchase its outstanding shares for $56.25 per share. In April 2024, Smartsheet’s Board of Directors approved a share repurchase program under which Smartsheet could repurchase up to $150 million of its outstanding stock. On July 8, 2024, the Consortium raised its offer to $56.50 per share, and reiterated that offer on August 21, 2024. According to the lawsuit, while these offers were on the table and unknown to the investing public, Smartsheet was repurchasing its common stock at market prices significantly below the prices offered by the Consortium. Smartsheet had an obligation to disclose that it had received a formal acquisition offer from the Consortium or abstain from purchasing Smartsheet stock from unsuspecting investors.

During the Class Period, Smartsheet’s average stock price was $46.45 per share. On Tuesday, September 24, 2024, during pre-market hours, Smartsheet disclosed the transaction with the Consortium. The merger eventually closed on January 22, 2025, with the Consortium acquiring Smartsheet for $56.50 per share.

To join the Smartsheet class action, go to https://rosenlegal.com/cases/smartsheet-inc-2026/join call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/smar-investors-have-opportunity-to-lead-smartsheet-inc-securities-fraud-lawsuit-302870367.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

WIX Deadline: WIX Investors with Losses in Excess of $100K Have Opportunity to Lead Wix.com Ltd. Securities Fraud Lawsuit

PR Newswire

NEW YORK, Sept. 5, 2026 /PRNewswire/ —

Rosen Law Firm Logo

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Wix.com Ltd. (NASDAQ: WIX) between February 19, 2025 and May 12, 2026, inclusive (the “Class Period”), of the important September 22, 2026 lead plaintiff deadline.

So what: If you purchased Wix securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Wix class action, go to https://rosenlegal.com/cases/wixcom-ltd/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 22, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Wix had overstated the competitiveness and performance of its AI product offerings relative to those offered by other companies; (2) Wix had understated the costs associated with developing and promoting its AI product offerings; (3) accordingly, defendants overstated the commercial and financial benefits of Wix’s AI product offerings; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Wix class action, go to https://rosenlegal.com/cases/wixcom-ltd/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/wix-deadline-wix-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-wixcom-ltd-securities-fraud-lawsuit-302870464.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PR Newswire

Did you buy
HIMS
securities between August 4, 2025 and July 29, 2026?

Affected HIMS Investor Summary

  • Who: Hims & Hers Health, Inc. (NYSE: HIMS)
  • What: Securities fraud class action lawsuit filed
  • Class Period: August 4, 2025 through July 29, 2026
  • Deadline to Seek Lead Plaintiff Status: November 2, 2026
  • Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s deceptive and unlawful privacy practices
  • Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options

RADNOR, Pa., Sept. 5, 2026 /PRNewswire/ — Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS) (NYSE: HIMS) on behalf of those who purchased or acquired HIMS securities between August 4, 2025 and July 29, 2026, inclusive. The lawsuit is filed in the United States District Court for the Northern District of California and is captioned Velanki v. Hims & Hers Health, Inc., No. 26-cv-09313 (N.D. Cal.). Investors have until November 2, 2026, to file for lead plaintiff status. 

KTMC (PRNewsFoto/Kessler Topaz Meltzer & Check)


CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:


If you purchased or acquired HIMS securities and have lost money on your investment, please provide your information here:
https://www.ktmc.com/hims-hims-hers-inc-class-action-lawsuit?utm_campaign=hc?utm_source=PR_Newswire&utm_medium=pressrelease&utm_campaign=hims&mktm=PR 

To view the HIMS video on YouTube, click here:
https://youtu.be/zCS_-D0Ocv4

You can also contact attorney

Jonathan Naji, Esq.
 by calling (484) 270-1453 or by email at [email protected]. There is no cost or obligation to speak with an attorney.


HIMS & HERS HEALTH, INC.
 CLASS ACTION LAWSUIT – COMPLAINT ALLEGATION SUMMARY:
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) HIMS shared consumers’ health information with third-party advertising platforms; (2) HIMS charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is “right for them;” (3) the foregoing conduct subjected HIMS to regulatory scrutiny; (4) as a result, HIMS was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, Defendants’ positive statements about the company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Why did HIMS’s Stock Drop?
On July 29, 2026, the Federal Trade Commission (“FTC”) filed a lawsuit against HIMS accusing the company of sharing customers’ medical information with third-party advertisers. Specifically,

the FTC’s criminal complaint accuses HIMS of “deceptive and unlawful privacy practices,” including sharing sensitive details about a patient’s health with Snap and Facebook parent, Meta Platforms. On this news, HIMS’s stock price declined $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026.


WHAT HIMS & HERS HEALTH, INC. INVESTORS CAN DO NOW:

  1. File to be lead plaintiff by November 2, 2026.
  2. Contact KTMC for a free case evaluation. All representation is on a contingency fee basis, there is no cost to you.
  3. Retain counsel of choice or take no action.


THE LEAD PLAINTIFF PROCESS FOR HIMS & HERS HEALTH, INC. INVESTORS:

HIMS investors may, no later than November 2, 2026, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages HIMS investors to contact the firm for more information.


ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):


Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including being recognized in Chambers & Partners USA 2026 as a Band 1 Top Firm in Securities and Class Actions, Legal 500’s Tier 1 Rankings for Securities and M&A Litigation, The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent. The complaint in this matter was not filed by KTMC.

CONTACT:
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected] 

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-deadline-alert-hims–hers-health-inc-hims-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302870300.html

SOURCE Kessler Topaz Meltzer & Check, LLP